comparemela.com

Page 3 - Swiss Innovation Agency News Today : Breaking News, Live Updates & Top Stories | Vimarsana

University and businesses collaborate to unlock safe green energy solution

Three-year R&D project is backed by funding of more than £3m

United kingdomGuoyu yuDavid walkerZeeko ltdCentre for precision technologiesUs national ignition facilityUniversity of huddersfieldA university of huddersfieldSwiss innovation agencyMetal films ltdLaboratory for ultra precisionFreeforms optics systemsUltra precision surfacesThin metal films ltdApplied universityIgnition facility

Gain Therapeutics Strengthens Management Team and Appoints Jonas Hannestad, M D , Ph D as Chief Medical Officer

BETHESDA, Md., April 01, 2024 Gain Therapeutics, Inc. , a clinical-stage biotechnology company leading the discovery and development of the next generation allosteric small molecule therapies,.

Elio ambrosioNic johnsonJonas hannestadBristol myers squibbMatthias alderGain therapeutics incNeuropsychiatric instituteExchange commission onCompany annual report on formDuke school of medicineClinical development at alkahestUniversity of oviedoEuropean union horizonMichaelj fox foundation for parkinson researchCompensation committee of gain board directorsSilverstein foundation for parkinson

Gain Therapeutics Strengthens Management Team and Appoints Jonas Hannestad, M D , Ph D as

BETHESDA, Md., April 01, 2024 (GLOBE NEWSWIRE) Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation

Nic johnsonBristol myers squibbElio ambrosioJonas hannestadMatthias alderUniversity of messinaSilverstein foundation for parkinsonMichaelj fox foundation for parkinson researchClinical neuroscience research unitYale school of medicineCompensation committee of gain board directorsExchange commission onEuropean union horizonGain therapeutics incSwiss innovation agencyDuke school of medicine

NCBR: Next step in the implementation of the Swiss-Polish Cooperation Programme

On 13 February the National Centre for Research and Development signed the Memorandum of Understanding with Innosuisse – Swiss Innovation Agency on cooperation in the Applied Research Programme under the Second Swiss Contribution to Poland.

Research programmeCooperation programmeSwiss innovation agencyNational centre for researchScientific researchInnovation programmeNational centreApplied research programmeSecond swiss contributionSwiss polish cooperation programmeSwiss innovation

Smart Immune appoints key new members to its Board of Directors

Smart Immune appoints key new members to its Board of Directors
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

France generalUnited statesMitem pharmaFederico mingozziPonts paristechFouzia laghrissi thodeKarine rossignolJean pierre bizzariPablo silveriMarkus goebelDominique costantiniSwiss innovation agencyDrug committeeDow chemical companyBoard of the european organization for researchNovartis venture fund

vimarsana © 2020. All Rights Reserved.